Eric A. Murphy
RG Biopharma (United States)(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Lung Cancer Treatments and Mutations, Cell Adhesion Molecules Research, Nanoparticle-Based Drug Delivery, Angiogenesis and VEGF in Cancer
Most-Cited Works
- → A role for VEGF as a negative regulator of pericyte function and vessel maturation(2008)614 cited
- → MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis(2010)519 cited
- → Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis(2008)453 cited
- → The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation(1996)148 cited
- → Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane(2011)140 cited
- → EGF816 Exerts Anticancer Effects in Non–Small Cell Lung Cancer by Irreversibly and Selectively Targeting Primary and Acquired Activating Mutations in the EGF Receptor(2016)121 cited
- → Targeted Nanogels: A Versatile Platform for Drug Delivery to Tumors(2011)83 cited
- → Formation of endothelial lumens requires a coordinated PKCϵ-, Src-, Pak- and Raf-kinase-dependent signaling cascade downstream of Cdc42 activation(2009)83 cited
- → RBBP9: A tumor-associated serine hydrolase activity required for pancreatic neoplasia(2009)74 cited
- → A MEK-independent role for CRAF in mitosis and tumor progression(2011)70 cited